EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. (2022)

First Author: Landewé RBM
Attributed to:  Experimental Medicine INitiative to Explore New Therapies - Phase 2 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2021-222006

PubMed Identifier: 35197264

Publication URI: http://europepmc.org/abstract/MED/35197264

Type: Journal Article/Review

Volume: 81

Parent Publication: Annals of the rheumatic diseases

Issue: 12

ISSN: 0003-4967